Psychotropic Drug Prescription Practice in Psychiatric In-Patients in Saskatchewan, Canada | OMICS International| Abstract

Clinical Neuropsychology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Neuropsychopharmacol Mental Health,
  • DOI: 10.4172/2472-095X.1000114

Psychotropic Drug Prescription Practice in Psychiatric In-Patients in Saskatchewan, Canada

Adelugba Olajide1*, Mela Mansfield2, Obikoya Olubankole3 and Okpalauwaekwe Udoka2
1Regional Psychiatric Centre, , Saskatoon, SK S7K 3X5, Canada
2Irene and Leslie Dube Centre for Mental Health, Royal University Hospital, , Saskatoon, SK S7N 0W8, Canada
3Saskatchewan Hospital, , North Battleford, SK S9A 2X8, Canada
*Corresponding Author : Adelugba Olajide, Regional Psychiatric Centre, Saskatoon, SK S7K 3X5, Canada, Tel: +1-306-370-2111, Email: [email protected]

Received Date: Aug 22, 2016 / Accepted Date: Sep 19, 2016 / Published Date: Sep 22, 2016


Background: Psychotropic drugs play a huge role in providing care in psychiatric and mental health. The judicious and appropriate use of these medications goes a long way in providing improved quality of health among psychiatric inpatients in Canada.
Objective: To appraise the prevalence, pattern, and rational for psychotropic drugs prescription in different psychiatric inpatient settings in Saskatchewan, Canada.
Material and methods: We conducted a one-day cross-sectional study at three psychiatric treatment facilities in Saskatchewan, Canada. They were: a) Regional Psychiatric Centre in Saskatoon (RPC); b) Saskatchewan Hospital in North Battleford (SH); and c) Dubé Centre for Mental Health in Saskatoon (DC). Data were collected blindly from selected patients’ records in these centres and analyzed using the Statistical Package for Social Science (SPSS) version 21.
Results: A total of 381 patients’ records were retrieved and distributed in the three sites; RPC (47.5%), SH (36.5%) and DC (16%). The majority of in-patients were males (76.6%) and between the ages of 25 to 65 years. Schizophrenia was the most Axis 1 DSM-IV psychiatric diagnosis (46.2% counts for all patients) with Saskatchewan Hospital having the highest percentage (61.8%) of patients diagnosed. We calculated a total of 2275 regular prescriptions and 1322 pro re nata (PRN) prescriptions. The mean number of regular and PRN psychotropic medications per patient were 2.83 and 1.38 respectively. The most commonly prescribed drugs were benzodiazepines with Lorazepam being the most prescribed PRN psychotropic drug.
Conclusions: To ensure more judicious use of psychotropic medications, assessment, and management of patients’ short and long-term outcomes, including clinical evaluation of the benefits and side effects of these drugs are vital.

Keywords: Psychotropic drugs; Psychotropic medications; Drug distribution; Drug prescription; Psychiatric inpatient; Saskatchewan

Citation: Olajide A, Mansfield M, Olubankole O, Udoka O (2016) Psychotropic Drug Prescription Practice in Psychiatric In-Patients in Saskatchewan, Canada. J Neuropsychopharmacol Mental Health 1: 114. Doi: 10.4172/2472-095X.1000114

Copyright: © 2016 Olajide A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.